A clinical laboratory is validating a new quantitative blood assay for a tumor marker used to screen for a specific cancer. Initially, the test yields a high number of false-positive results, leading to patient anxiety and unnecessary invasive biopsies. To address this, the laboratory advisory committee decides to adjust the test's diagnostic threshold (cut-off value) so that a result is only considered 'positive' at a much higher serum concentration.
Assuming the underlying prevalence of the cancer in the screened population remains unchanged, which of the following statistical consequences is most likely to result directly from this threshold adjustment?
- Specificity of the test will increaseCevap
- BSensitivity of the test will increase
- CThe false-positive rate will increase
- DThe positive predictive value will decrease
- EThe false-negative rate will decrease
Cevap
Specificity of the test will increase
Diagnostic tests that use a continuous variable (like a serum biomarker concentration) require a defined cut-off point to distinguish between a 'positive' and 'negative' result. When this threshold is raised, the criteria to be diagnosed as positive become stricter. Consequently, fewer patients without the disease will accidentally cross the threshold, leading to a decrease in the false-positive rate. Because specificity is defined as the proportion of true negatives out of all individuals without the disease, a reduction in false positives directly translates to an increase in specificity. This adjustment always comes at a trade-off, as it simultaneously increases the false-negative rate and decreases sensitivity.
Adım Adım Çözüm
Anahtar Kavram
Adjusting diagnostic test cut-off thresholds